|
1
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Connerty P, Lock RB and de Bock CE: Long
Non-coding RNAs: Major regulators of cell stress in cancer. Front
Oncol. 10:285. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
Initial sequencing and analysis of the human genome. Nature.
409:860–921. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
ENCODE Project Consortium, . Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jonas S and Izaurralde E: Towards a
molecular understanding of microRNA-mediated gene silencing. Nat
Rev Genet. 16:421–433. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Svoboda P: Renaissance of mammalian
endogenous RNAi. FEBS Lett. 588:2550–2556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roufayel R and Kadry S: MicroRNAs: Crucial
regulators of stress. Microrna. 9:93–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dahariya S, Paddibhatla I, Kumar S,
Raghuwanshi S, Pallepati A and Gutti RK: Long non-coding RNA:
Classification, biogenesis and functions in blood cells. Mol
Immunol. 112:82–92. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu PF, Zheng X, Fan X and Lin AF: Role of
cytoplasmic lncRNAs in regulating cancer signaling pathways. J
Zhejiang Univ Sci B. 20:1–8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Warburg O: The metabolism of carcinoma
cells. J Cancer Res. 9:148–163. 1925. View Article : Google Scholar
|
|
14
|
Papakonstantinou E, Vlachakis D, Thireou
T, Vlachoyiannopoulos PG and Eliopoulos E: A Holistic Evolutionary
and 3D pharmacophore modelling study provides insights into the
metabolism, function, and substrate selectivity of the human
monocarboxylate transporter 4 (hMCT4). Int J Mol Sci. 22:29182021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia D, Lu M, Jung KH, Park JH, Yu L,
Onuchic JN, Kaipparettu BA and Levine H: Elucidating cancer
metabolic plasticity by coupling gene regulation with metabolic
pathways. Proc Natl Acad Sci USA. 116:3909–3918. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang
S, Dong S, Wen Z, Rao J, Liao W and Shi M: The lncRNA MACC1-AS1
promotes gastric cancer cell metabolic plasticity via AMPK/Lin28
mediated mRNA stability of MACC1. Mol Cancer. 17:692018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X,
Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes
colorectal carcinogenesis and glucose metabolism by stabilizing
c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leucci E, Vendramin R, Spinazzi M,
Laurette P, Fiers M, Wouters J, Radaelli E, Eyckerman S, Leonelli
C, Vanderheyden K, et al: Melanoma addiction to the long non-coding
RNA SAMMSON. Nature. 531:518–522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao ZD, Han L, Lee H, Zhuang L, Zhang Y,
Baddour J, Nagrath D, Wood CG, Gu J, Wu X, et al: Energy
stress-induced lncRNA FILNC1 represses c-Myc-mediated energy
metabolism and inhibits renal tumor development. Nat Commun.
8:7832017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiang S, Gu H, Jin L, Thorne RF, Zhang XD
and Wu M: LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α
via IDH1 to regulate the Warburg effect. Proc Natl Acad Sci USA.
115:E1465–E1474. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Xiao ZD, Han L, Zhang J, Lee SW,
Wang W, Lee H, Zhuang L, Chen J, Lin HK, et al: LncRNA NBR2 engages
a metabolic checkpoint by regulating AMPK under energy stress. Nat
Cell Biol. 18:431–442. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kang Y, Zhu X, Xu Y, Tang Q, Huang Z, Zhao
Z, Lu J, Song G, Xu H, Deng C and Wang J: Energy stress-induced
lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and
inhibits osteosarcoma progression. Am J Cancer Res. 8:526–537.
2018.PubMed/NCBI
|
|
23
|
Wang WT, Ye H, Wei PP, Han BW, He B, Chen
ZH and Chen YQ: LncRNAs H19 and HULC, activated by oxidative
stress, promote cell migration and invasion in cholangiocarcinoma
through a ceRNA manner. J Hematol Oncol. 9:1172016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu ZR, Yan L, Liu YT, Cao L, Guo YH, Zhang
Y, Yao H, Cai L, Shang HB, Rui WW, et al: Inhibition of mTORC1 by
lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary
tumours. Nat Commun. 9:46242018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moreno Leon L, Gautier M, Allan R, Ilié M,
Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, et al:
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA
contributes to an aggressive phenotype in lung adenocarcinoma
through regulation of oxidative stress. Oncogene. 38:7146–7165.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bountali A, Tonge DP and
Mourtada-Maarabouni M: RNA sequencing reveals a key role for the
long non-coding RNA MIAT in regulating neuroblastoma and
glioblastoma cell fate. Int J Biol Macromol. 130:878–891. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Choudhry H, Schödel J, Oikonomopoulos S,
Camps C, Grampp S, Harris AL, Ratcliffe PJ, Ragoussis J and Mole
DR: Extensive regulation of the non-coding transcriptome by
hypoxia: Role of HIF in releasing paused RNApol2. EMBO Rep.
15:70–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Campisi J and d'Adda di Fagagna F:
Cellular senescence: When bad things happen to good cells. Nat Rev
Mol Cell Biol. 8:729–740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji X, Lu Y, Tian H, Meng X, Wei M and Cho
WC: Chemoresistance mechanisms of breast cancer and their
countermeasures. Biomed Pharmacother. 114:1088002019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Velegzhaninov IO, Ievlev VA, Pylina YI,
Shadrin DM and Vakhrusheva OM: Programming of cell resistance to
genotoxic and oxidative stress. Biomedicines. 6:52018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yao N, Fu Y, Chen L, Liu Z, He J, Zhu Y,
Xia T and Wang S: Long non-coding RNA NONHSAT101069 promotes
epirubicin resistance, migration, and invasion of breast cancer
cells through NONHSAT101069/miR-129-5p/Twist1 axis. Oncogene.
38:7216–7233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu WL, Jin L, Xu A, Wang YF, Thorne RF,
Zhang XD and Wu M: GUARDIN is a p53-responsive long non-coding RNA
that is essential for genomic stability. Nat Cell Biol. 20:492–502.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Taiana E, Favasuli V, Ronchetti D,
Todoerti K, Pelizzoni F, Manzoni M, Barbieri M, Fabris S,
Silvestris I, Gallo Cantafio ME, et al: Long non-coding RNA NEAT1
targeting impairs the DNA repair machinery and triggers anti-tumor
activity in multiple myeloma. Leukemia. 34:234–244. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gooding AJ, Zhang B, Gunawardane L, Beard
A, Valadkhan S and Schiemann WP: The lncRNA BORG facilitates the
survival and chemoresistance of triple-negative breast cancers.
Oncogene. 38:2020–2041. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hafner A, Bulyk ML, Jambhekar A and Lahav
G: The multiple mechanisms that regulate p53 activity and cell
fate. Nat Rev Mol Cell Biol. 20:199–210. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou CC, Yang F, Yuan SX, Ma JZ, Liu F,
Yuan JH, Bi FR, Lin KY, Yin JH, Cao GW, et al: Systemic genome
screening identifies the outcome associated focal loss of long
noncoding RNA PRAL in hepatocellular carcinoma. Hepatology.
63:850–863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kotake Y, Kitagawa K, Ohhata T, Sakai S,
Uchida C, Niida H, Naemura M and Kitagawa M: Long Non-coding RNA,
PANDA, contributes to the stabilization of p53 tumor suppressor
protein. Anticancer Res. 36:1605–1611. 2016.PubMed/NCBI
|
|
39
|
Jiang MC, Ni JJ, Cui WY, Wang BY and Zhuo
W: Emerging roles of lncRNA in cancer and therapeutic
opportunities. Am J Cancer Res. 9:1354–1366. 2019.PubMed/NCBI
|
|
40
|
Wang Z, Liu Y, Han N, Chen X, Yu W, Zhang
W and Zou F: Profiles of oxidative stress-related microRNA and mRNA
expression in auditory cells. Brain Res. 1346:14–25. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shen J, Xia W, Khotskaya YB, Huo L,
Nakanishi K, Lim SO, Du Y, Wang Y, Chang WC, Chen CH, et al: EGFR
modulates microRNA maturation in response to hypoxia through
phosphorylation of AGO2. Nature. 497:383–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rupaimoole R, Wu SY, Pradeep S, Ivan C,
Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand
B, et al: Hypoxia-mediated downregulation of miRNA biogenesis
promotes tumour progression. Nat Commun. 5:52022014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Saha SK, Lee SB, Won J, Choi HY, Kim K,
Yang GM, Dayem AA and Cho SG: Correlation between oxidative stress,
nutrition, and cancer initiation. Int J Mol Sci. 18:15442017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Degli Esposti D, Aushev VN, Lee E, Cros
MP, Zhu J, Herceg Z, Chen J and Hernandez-Vargas H: miR-500a-5p
regulates oxidative stress response genes in breast cancer and
predicts cancer survival. Sci Rep. 7:159662017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pajic M, Froio D, Daly S, Doculara L,
Millar E, Graham PH, Drury A, Steinmann A, de Bock CE,
Boulghourjian A, et al: miR-139-5p modulates radiotherapy
resistance in breast cancer by repressing multiple gene networks of
DNA repair and ROS defense. Cancer Res. 78:501–515. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Devlin C, Greco S, Martelli F and Ivan M:
miR-210: More than a silent player in hypoxia. IUBMB Life.
63:94–100. 2011.PubMed/NCBI
|
|
48
|
Yang M, Yao Y, Eades G, Zhang Y and Zhou
Q: MiR-28 regulates Nrf2 expression through a Keap1-independent
mechanism. Breast Cancer Res Treat. 129:983–991. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Niu J, Shi Y, Tan G, Yang CH, Fan M,
Pfeffer LM and Wu ZH: DNA damage induces NF-κB-dependent
microRNA-21 up-regulation and promotes breast cancer cell invasion.
J Biol Chem. 287:21783–21795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nakazawa K, Dashzeveg N and Yoshida K:
Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2
in the apoptotic response to DNA damage. FEBS J. 281:2937–2944.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Das AV and Pillai RM: Implications of miR
cluster 143/145 as universal anti-oncomiRs and their dysregulation
during tumorigenesis. Cancer Cell Int. 15:922015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gomes SE, Pereira DM, Roma-Rodrigues C,
Fernandes AR, Borralho PM and Rodrigues CMP: Convergence of miR-143
overexpression, oxidative stress and cell death in HCT116 human
colon cancer cells. PLoS One. 13:e0191607. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim SY, Lee YH and Bae YS: MiR-186,
miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular
senescence by targeting α subunit of protein kinase CKII in human
colorectal cancer cells. Biochem Biophys Res Commun. 429:173–179.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen Z, Li Y, Zhang H, Huang P and Luthra
R: Hypoxia-regulated microRNA-210 modulates mitochondrial function
and decreases ISCU and COX10 expression. Oncogene. 29:4362–4368.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wan Y, Cui R, Gu J, Zhang X, Xiang X, Liu
C, Qu K and Lin T: Identification of four oxidative
stress-responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and
miR-150-3p, in Hepatocellular carcinoma. Oxid Med Cell Longev.
2017:51891382017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bai XY, Ma Y, Ding R, Fu B, Shi S and Chen
XM: miR-335 and miR-34a Promote renal senescence by suppressing
mitochondrial antioxidative enzymes. J Am Soc Nephrol.
22:1252–1261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li D, Wang Q, Liu C, Duan H, Zeng X, Zhang
B, Li X, Zhao J, Tang S, Li Z, et al: Aberrant expression of
miR-638 contributes to Benzo(a)pyrene-induced human cell
transformation. Toxicol Sci. 125:382–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Scisciani C, Vossio S, Guerrieri F,
Schinzari V, De Iaco R, D'Onorio de Meo P, Cervello M, Montalto G,
Pollicino T, Raimondo G, et al: Transcriptional regulation of
miR-224 upregulated in human HCCs by NFκB inflammatory pathways. J
Hepatol. 56:855–861. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cardin R, Piciocchi M, Sinigaglia A,
Lavezzo E, Bortolami M, Kotsafti A, Cillo U, Zanus G, Mescoli C,
Rugge M and Farinati F: Oxidative DNA damage correlates with cell
immortalization and mir-92 expression in hepatocellular carcinoma.
BMC Cancer. 12:1772012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sun M, Hong S, Li W, Wang P, You J, Zhang
X, Tang F, Wang P and Zhang C: miR-99a regulates ROS-mediated
invasion and migration of lung adenocarcinoma cells by targeting
NOX4. Oncol Rep. 35:2755–2766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lee KR, Lee JS, Song JE, Ha SJ and Hong
EK: Inonotus obliquus-derived polysaccharide inhibits the migration
and invasion of human non-small cell lung carcinoma cells via
suppression of MMP-2 and MMP-9. Int J Oncol. 45:2533–2540. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yin M, Ren X, Zhang X, Luo Y, Wang G,
Huang K, Feng S, Bao X, Huang K, He X, et al: Selective killing of
lung cancer cells by miRNA-506 molecule through inhibiting NF-κB
p65 to evoke reactive oxygen species generation and p53 activation.
Oncogene. 34:691–703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xu X, Wells A, Padilla MT, Kato K, Kim KC
and Lin Y: A signaling pathway consisting of miR-551b, catalase and
MUC1 contributes to acquired apoptosis resistance and
chemoresistance. Carcinogenesis. 35:2457–2466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cortez MA, Valdecanas D, Zhang X, Zhan Y,
Bhardwaj V, Calin GA, Komaki R, Giri DK, Quini CC, Wolfe T, et al:
Therapeutic delivery of miR-200c enhances radiosensitivity in lung
cancer. Mol Ther. 22:1494–1503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Dai F, Zhang Y and Chen Y: Involvement of
miR-29b signaling in the sensitivity to chemotherapy in patients
with ovarian carcinoma. Hum Pathol. 45:1285–1293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hou M, Zuo X, Li C, Zhang Y and Teng Y:
Mir-29b regulates oxidative stress by targeting SIRT1 in ovarian
cancer cells. Cell Physiol Biochem. 43:1767–1776. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: miR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kozak J, Wdowiak P, Maciejewski R and
Torres A: Interactions between microRNA-200 family and Sestrin
proteins in endometrial cancer cell lines and their significance to
anoikis. Mol Cell Biochem. 459:21–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Liu Y, Qiang W, Xu X, Dong R, Karst AM,
Liu Z, Kong B, Drapkin RI and Wei JJ: Role of miR-182 in response
to oxidative stress in the cell fate of human fallopian tube
epithelial cells. Oncotarget. 6:38983–38998. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
He J, Jing Y, Li W, Qian X, Xu Q, Li FS,
Liu LZ, Jiang BH and Jiang Y: Roles and mechanism of miR-199a and
miR-125b in tumor angiogenesis. PLoS One. 8:e566472013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yang Z, Chen JS, Wen JK, Gao HT, Zheng B,
Qu CB, Liu KL, Zhang ML, Gu JF, Li JD, et al: Silencing of
miR-193a-5p increases the chemosensitivity of prostate cancer cells
to docetaxel. J Exp Clin Cancer Res. 36:1782017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Jajoo S, Mukherjea D, Kaur T, Sheehan KE,
Sheth S, Borse V, Rybak LP and Ramkumar V: Essential role of NADPH
oxidase-dependent reactive oxygen species generation in regulating
microRNA-21 expression and function in prostate cancer. Antioxid
Redox Signal. 19:1863–1876. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nilsson EM, Laursen KB, Whitchurch J,
McWilliam A, Ødum N, Persson JL, Heery DM, Gudas LJ and Mongan NP:
MiR137 is an androgen regulated repressor of an extended network of
transcriptional coregulators. Oncotarget. 6:35710–35725. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lu JP, Monardo L, Bryskin I, Hou ZF,
Trachtenberg J, Wilson BC and Pinthus JH: Androgens induce
oxidative stress and radiation resistance in prostate cancer cells
though NADPH oxidase. Prostate Cancer Prostatic Dis. 13:39–46.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Queiroz EA, Puukila S, Eichler R, Sampaio
SC, Forsyth HL, Lees SJ, Barbosa AM, Dekker RF, Fortes ZB and
Khaper N: Metformin induces apoptosis and cell cycle arrest
mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast
cancer cells. PLoS One. 9:e982072014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yang J, Wei J, Wu Y, Wang Z, Guo Y, Lee P
and Li X: Metformin induces ER stress-dependent apoptosis through
miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis.
4:e1582015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ma Y, Yang HZ, Dong BJ, Zou HB, Zhou Y,
Kong XM and Huang YR: Biphasic regulation of autophagy by miR-96 in
prostate cancer cells under hypoxia. Oncotarget. 5:9169–9182. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mazure NM and Pouysségur J:
Hypoxia-induced autophagy: Cell death or cell survival? Curr Opin
Cell Biol. 22:177–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu Y, Li X, Zhu S, Zhang JG, Yang M, Qin
Q, Deng SC, Wang B, Tian K, Liu L, et al: Ectopic expression of
miR-494 inhibited the proliferation, invasion and chemoresistance
of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther.
22:729–738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang P, Zhu CF, Ma MZ, Chen G, Song M,
Zeng ZL, Lu WH, Yang J, Wen S, Chiao PJ, et al: Micro-RNA-155 is
induced by K-Ras oncogenic signal and promotes ROS stress in
pancreatic cancer. Oncotarget. 6:21148–21158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Binker-Cosen MJ, Richards D, Oliver B,
Gaisano HY, Binker MG and Cosen-Binker LI: Palmitic acid increases
invasiveness of pancreatic cancer cells AsPC-1 through
TLR4/ROS/NF-κB/MMP-9 signaling pathway. Biochem Biophys Res Commun.
484:152–158. 2017. View Article : Google Scholar : PubMed/NCBI
|
